HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

arepanrix

an AD03-adjuvanated H1N1 vaccine

Networked: 10 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Viral Vaccines: 462
      - Influenza Vaccines: 6582
        arepanrix: 10

Experts

1.	Mignot, Emmanuel: 3 articles (10/2020 - 07/2015)
2.	Edwards, Kathryn: 2 articles (07/2019 - 01/2019)
3.	Nohynek, Hanna: 2 articles (07/2019 - 01/2014)
4.	Adams, Christopher: 1 article (10/2020)
5.	Ambati, Aditya: 1 article (10/2020)
6.	Leib, Ryan D: 1 article (10/2020)
7.	Lin, Ling: 1 article (10/2020)
8.	Louis, Jacob: 1 article (10/2020)
9.	Luo, Guo: 1 article (10/2020)
10.	Ollila, Hanna Maria: 1 article (10/2020)

Related Diseases

1.	Narcolepsy 01/01/2019 - "In contrast, studies from Canada of a similar AS03-adjuvanted vaccine, Arepanrix, did not demonstrate a similar increased risk of narcolepsy. " 07/01/2015 - "Our aim was to characterize the differences between Pandemrix and Arepanrix that might explain the risk for narcolepsy after Pandemrix vaccination using 2D-DIGE and mass spectrometry (MS). " 10/30/2020 - "Pandemrix harbored lower mutational burden than Arepanrix, indicating higher similarity to wild-type 2009 pH1N1, which could explain differences in narcolepsy susceptibility amongst the vaccines." 07/01/2015 - "The presence of 146N in large relative amounts in Pandemrix and the wild type virus and in lower relative quantities in Arepanrix or other H1N1 vaccines may have affected predisposition to narcolepsy. " 07/01/2015 - "Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development."
2.	Human Influenza (Influenza) 01/01/2018 - "Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada." 07/01/2010 - "A single 0.25-ml dose of the GSK adjuvanted vaccine (Arepanrix) protects children against laboratory-confirmed pandemic influenza potentially avoiding any increased reactogenicity associated with second doses. " 07/01/2010 - "To report a case of Guillain-Barré syndrome (GBS) following a dose of influenza A (H1N1) vaccine (Arepanrix). " 08/01/2010 - "The objective of this study was to estimate the risk of anaphylaxis in children with egg allergy administered an adjuvanted monovalent 2009 pandemic influenza A/H1N1 influenza vaccine (Arepanrix; GlaxoSmithKline, Mississauga, Ontario, Canada). " 10/30/2020 - "The four most abundant influenza proteins across both vaccines were nucleoprotein NP, hemagglutinin HA, matrix protein M1, with the exception that Pandemrix harbored a significantly increased proportion of neuraminidase NA (7.5%) as compared to Arepanrix (2.6%). "
3.	Egg Hypersensitivity (Egg Allergy) 08/01/2010 - "The objective of this study was to estimate the risk of anaphylaxis in children with egg allergy administered an adjuvanted monovalent 2009 pandemic influenza A/H1N1 influenza vaccine (Arepanrix; GlaxoSmithKline, Mississauga, Ontario, Canada). "
4.	Anaphylaxis (Anaphylactic Shock) 08/01/2010 - "The objective of this study was to estimate the risk of anaphylaxis in children with egg allergy administered an adjuvanted monovalent 2009 pandemic influenza A/H1N1 influenza vaccine (Arepanrix; GlaxoSmithKline, Mississauga, Ontario, Canada). "
5.	Guillain-Barre Syndrome 07/01/2010 - "To report a case of Guillain-Barré syndrome (GBS) following a dose of influenza A (H1N1) vaccine (Arepanrix). "

Related Drugs and Biologics

1.	Vaccines
2.	Influenza Vaccines (Influenza Vaccine)
3.	pandemrix
4.	Antibodies
5.	Orexin Receptors
6.	Proteins (Proteins, Gene)
7.	Nucleoproteins
8.	Neuraminidase (Sialidase)
9.	Hemagglutinins (Hemagglutinin)
10.	Detergents (Detergent)